Karyopharm Therapeutics Inc (KPTI) revenue is $44.0M
Karyopharm Therapeutics Inc (KPTI) revenue is $44.0M as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full KPTI research page for quote, filings, and the rest of the model. This satellite exists so “Karyopharm Therapeutics Inc revenue” can rank with the actual number, then send you to /stock/kpti.